Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (1523)
All Articles published online
|
Feb 28, 2007 (publication date) through Apr 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ding XW, Yan JJ, An P, Lü P, Luo HS. Aberrant expression of ether à go-go potassium channel in colorectal cancer patients and cell lines. World J Gastroenterol 2007; 13(8): 1257-1261 [PMID: 17451210 DOI: 10.3748/wjg.v13.i8.1257] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i8/1257.htm |
| Number | Citing Articles |
| 1 |
Ye Chen, Araceli Sánchez, María E. Rubio, Tobias Kohl, Luis A. Pardo, Walter Stühmer, Sven G. Meuth. Functional KV10.1 Channels Localize to the Inner Nuclear Membrane. PLoS ONE 2011; 6(5): e19257 doi: 10.1371/journal.pone.0019257
|
| 2 |
Xinyu Wu, Zhida Chen, Wengrong Zeng, Yuanfu Zhong, Qingjun Liu, Jin Wu. Silencing ofEag1Gene Inhibits Osteosarcoma Proliferation and Migration by Targeting STAT3-VEGF Pathway. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/617316
|
| 3 |
Thais Torquato Sales, Fernando Francisco Borges Resende, Natália Lemos Chaves, Simoneide Souza Titze-De-Almeida, Sônia Nair Báo, Marcella Lemos Brettas, Ricardo Titze-De-Almeida. Suppression of the Eag1 potassium channel sensitizes glioblastoma cells to injury caused by temozolomide. Oncology Letters 2016; 12(4): 2581 doi: 10.3892/ol.2016.4992
|
| 4 |
Catherine J. Hutchings, Paul Colussi, Theodore G. Clark. Ion channels as therapeutic antibody targets. mAbs 2019; 11(2): 265 doi: 10.1080/19420862.2018.1548232
|
| 5 |
Huixian Lin, Zhe Li, Chang Chen, Xiaobin Luo, Jiening Xiao, Deli Dong, Yanjie Lu, Baofeng Yang, Zhiguo Wang, Stuart E. Dryer. Transcriptional and Post-Transcriptional Mechanisms for Oncogenic Overexpression of Ether À Go-Go K+ Channel. PLoS ONE 2011; 6(5): e20362 doi: 10.1371/journal.pone.0020362
|
| 6 |
Viren Asher, Heidi Sowter, Robert Shaw, Anish Bali, Raheela Khan. Eag and HERG potassium channels as novel therapeutic targets in cancer. World Journal of Surgical Oncology 2010; 8(1) doi: 10.1186/1477-7819-8-113
|
| 7 |
Indranil Chattopadhyay, Avninder Singh, Rupkumar Phukan, Joydeep Purkayastha, Amal Kataki, Jagadish Mahanta, Sunita Saxena, Sujala Kapur. Genome-wide analysis of chromosomal alterations in patients with esophageal squamous cell carcinoma exposed to tobacco and betel quid from high-risk area in India. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 2010; 696(2): 130 doi: 10.1016/j.mrgentox.2010.01.001
|
| 8 |
Gui-Ming Zhang, Fang-Ning Wan, Xiao-Jian Qin, Da-Long Cao, Hai-Liang Zhang, Yao Zhu, Bo Dai, Guo-Hai Shi, Ding-Wei Ye. Prognostic significance of the TREK-1 K2P potassium channels in prostate cancer. Oncotarget 2015; 6(21): 18460 doi: 10.18632/oncotarget.3782
|
| 9 |
Ileana Hernandez-Resendiz, Franziska Hartung, Luis A. Pardo. Antibodies Targeting KVPotassium Channels: A Promising Treatment for Cancer. Bioelectricity 2019; 1(3): 180 doi: 10.1089/bioe.2019.0022
|
| 10 |
Dina Cosme, Maria Manuela Estevinho, Florian Rieder, Fernando Magro. Potassium channels in intestinal epithelial cells and their pharmacological modulation: a systematic review. American Journal of Physiology-Cell Physiology 2021; 320(4): C520 doi: 10.1152/ajpcell.00393.2020
|
| 11 |
Diana Urrego, Naira Movsisyan, Roser Ufartes, Luis A. Pardo. Periodic expression of Kv10.1 driven by pRb/E2F1 contributes to G2/M progression of cancer and non-transformed cells. Cell Cycle 2016; 15(6): 799 doi: 10.1080/15384101.2016.1138187
|
| 12 |
Jessica Iorio, Lisa Lastraioli, Elena Lastraioli. Potassium in Human Health. Physiology 2022; 12 doi: 10.5772/intechopen.101108
|
| 13 |
Ramón Martínez, Walter Stühmer, Sabine Martin, Julian Schell, Andrea Reichmann, Veit Rohde, Luis Pardo. Analysis of the expression of Kv10.1 potassium channel in patients with brain metastases and glioblastoma multiforme: impact on survival. BMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1848-y
|
| 14 |
Luis A Pardo, Walter Stühmer. Eag1 as a cancer target. Expert Opinion on Therapeutic Targets 2008; 12(7): 837 doi: 10.1517/14728222.12.7.837
|
| 15 |
Halima Ouadid-Ahidouch, Ahmed Ahidouch, Luis A. Pardo. Kv10.1 K+ channel: from physiology to cancer. Pflügers Archiv - European Journal of Physiology 2016; 468(5): 751 doi: 10.1007/s00424-015-1784-3
|
| 16 |
Vidhya Rao, Mathew Perez-Neut, Simon Kaja, Saverio Gentile. Voltage-Gated Ion Channels in Cancer Cell Proliferation. Cancers 2015; 7(2): 849 doi: 10.3390/cancers7020813
|
| 17 |
Lien Moreels, Steve Peigneur, Diogo Galan, Edwin De Pauw, Lászlo Béress, Etienne Waelkens, Luis Pardo, Loïc Quinton, Jan Tytgat. APETx4, a Novel Sea Anemone Toxin and a Modulator of the Cancer-Relevant Potassium Channel KV10.1. Marine Drugs 2017; 15(9): 287 doi: 10.3390/md15090287
|
| 18 |
Xiang-Wu Ding, Xiang-Gui Wang, He-Sheng Luo, Shi-Yun Tan, Shan Gao, Bing Luo, Hua Jiang. Expression and Prognostic Roles of Eag1 in Resected Esophageal Squamous Cell Carcinomas. Digestive Diseases and Sciences 2008; 53(8): 2039 doi: 10.1007/s10620-007-0116-7
|
| 19 |
T Ishiguro, H Avila, S-Y Lin, T Nakamura, M Yamamoto, D D Boyd. Gene trapping identifies chloride channel 4 as a novel inducer of colon cancer cell migration, invasion and metastases. British Journal of Cancer 2010; 102(4): 774 doi: 10.1038/sj.bjc.6605536
|
| 20 |
Lien Moreels, Steve Peigneur, Yoko Yamaguchi, Kim Vriens, Etienne Waelkens, Shunyi Zhu, Karin Thevissen, Bruno P.A. Cammue, Kazuki Sato, Jan Tytgat. Expanding the pharmacological profile of κ-hefutoxin 1 and analogues: A focus on the inhibitory effect on the oncogenic channel Kv10.1. Peptides 2017; 98: 43 doi: 10.1016/j.peptides.2016.08.008
|
| 21 |
Žan Toplak, Louise A. Hendrickx, Reham Abdelaziz, Xiaoyi Shi, Steve Peigneur, Tihomir Tomašič, Jan Tytgat, Lucija Peterlin‐Mašič, Luis A. Pardo. Overcoming challenges of HERG potassium channel liability through rational design: Eag1 inhibitors for cancer treatment. Medicinal Research Reviews 2022; 42(1): 183 doi: 10.1002/med.21808
|
| 22 |
Nirakar Sahoo, Kefan Yang, Ina Coburger, Alisa Bernert, Sandip M. Swain, Guido Gessner, Reinhard Kappl, Toni Kühl, Diana Imhof, Toshinori Hoshi, Roland Schönherr, Stefan H. Heinemann. Intracellular hemin is a potent inhibitor of the voltage-gated potassium channel Kv10.1. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-18975-2
|
| 23 |
Sarah Williams, Andrew Bateman, Ita O'Kelly, Sven G. Meuth. Altered Expression of Two-Pore Domain Potassium (K2P) Channels in Cancer. PLoS ONE 2013; 8(10): e74589 doi: 10.1371/journal.pone.0074589
|
| 24 |
Claudia Duranti, Annarosa Arcangeli. Ion Channel Targeting with Antibodies and Antibody Fragments for Cancer Diagnosis. Antibodies 2019; 8(2): 33 doi: 10.3390/antib8020033
|
| 25 |
Luis A. Pardo, Walter Stühmer. The roles of K+ channels in cancer. Nature Reviews Cancer 2014; 14(1): 39 doi: 10.1038/nrc3635
|
| 26 |
A. Innamaa, L. Jackson, V. Asher, G. van Schalkwyk, A. Warren, A. Keightley, D. Hay, A. Bali, H. Sowter, R. Khan. Expression and effects of modulation of the K2P potassium channels TREK-1 (KCNK2) and TREK-2 (KCNK10) in the normal human ovary and epithelial ovarian cancer. Clinical and Translational Oncology 2013; 15(11): 910 doi: 10.1007/s12094-013-1022-4
|
| 27 |
Qingxuan Lai, Ting Wang, Qingqing Guo, Yuxiang Zhang, Youxin Wang, Li Yuan, Rui Ling, Yan He, Wei Wang. Positive correlation between the expression of hEag1 and HIF-1α in breast cancers: an observational study. BMJ Open 2014; 4(5): e005049 doi: 10.1136/bmjopen-2014-005049
|
| 28 |
Gulimirerouzi Fnu, Georg F. Weber. Alterations of Ion Homeostasis in Cancer Metastasis: Implications for Treatment. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.765329
|
| 29 |
Nuria Comes, Antonio Serrano-Albarrás, Jesusa Capera, Clara Serrano-Novillo, Enric Condom, Santiago Ramón y Cajal, Joan Carles Ferreres, Antonio Felipe. Involvement of potassium channels in the progression of cancer to a more malignant phenotype. Biochimica et Biophysica Acta (BBA) - Biomembranes 2015; 1848(10): 2477 doi: 10.1016/j.bbamem.2014.12.008
|
| 30 |
Xiang‐Wu Ding, He‐Sheng Luo, Bing Luo, Dong‐Qiang Xu, Shan Gao. Overexpression of hERG1 in resected esophageal squamous cell carcinomas: A marker for poor prognosis. Journal of Surgical Oncology 2008; 97(1): 57 doi: 10.1002/jso.20891
|
| 31 |
Hisae Tateishi-Karimata, Keiko Kawauchi, Naoki Sugimoto. Destabilization of DNA G-Quadruplexes by Chemical Environment Changes during Tumor Progression Facilitates Transcription. Journal of the American Chemical Society 2018; 140(2): 642 doi: 10.1021/jacs.7b09449
|
| 32 |
|
| 33 |
Walter Stühmer, Luis A Pardo. K+ channels as therapeutic targets in oncology. Future Medicinal Chemistry 2010; 2(5): 745 doi: 10.4155/fmc.10.24
|
| 34 |
Diana Urrego, Adam P. Tomczak, Farrah Zahed, Walter Stühmer, Luis A. Pardo. Potassium channels in cell cycle and cell proliferation. Philosophical Transactions of the Royal Society B: Biological Sciences 2014; 369(1638): 20130094 doi: 10.1098/rstb.2013.0094
|
| 35 |
Heike Wulff, Neil A. Castle, Luis A. Pardo. Voltage-gated potassium channels as therapeutic targets. Nature Reviews Drug Discovery 2009; 8(12): 982 doi: 10.1038/nrd2983
|
| 36 |
Joanna Napp, Luis A. Pardo, Franziska Hartung, Lutz F. Tietze, Walter Stühmer, Frauke Alves. In vivo imaging of tumour xenografts with an antibody targeting the potassium channel Kv10.1. European Biophysics Journal 2016; 45(7): 721 doi: 10.1007/s00249-016-1152-z
|